tradingkey.logo

Rapid Micro Biosystems Inc

RPID
3.205USD
+0.055+1.75%
交易中 美东报价延迟15分钟
142.01M总市值
亏损市盈率 TTM

Rapid Micro Biosystems Inc

3.205
+0.055+1.75%

关于 Rapid Micro Biosystems Inc 公司

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc简介

公司代码RPID
公司名称Rapid Micro Biosystems Inc
上市日期Jul 15, 2021
CEOSpignesi (Robert)
员工数量163
证券类型Ordinary Share
年结日Jul 15
公司地址25 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02421
电话19783493200
网址https://www.rapidmicrobio.com/
公司代码RPID
上市日期Jul 15, 2021
CEOSpignesi (Robert)

Rapid Micro Biosystems Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Product revenue
4.42M
60.85%
Service revenue
2.84M
39.15%
地区USD
名称
营收
占比
United States
2.36M
32.54%
Germany
2.00M
27.61%
Switzerland
1.64M
22.54%
All other countries
961.00K
13.23%
Japan
296.00K
4.08%
业务
地区
业务USD
名称
营收
占比
Product revenue
4.42M
60.85%
Service revenue
2.84M
39.15%

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
8.93%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
其他
47.17%
持股股东
持股股东
占比
Bain Capital Life Sciences Investors, LLC
21.18%
Kennedy Lewis Investment Management LLC
12.40%
Longitude Capital Management Co., LLC
8.93%
Endeavour Medtech Growth II LP
5.67%
Ally Bridge Group (HK) Limited
4.64%
其他
47.17%
股东类型
持股股东
占比
Investment Advisor
37.21%
Venture Capital
8.99%
Investment Advisor/Hedge Fund
6.65%
Corporation
5.67%
Hedge Fund
4.22%
Individual Investor
4.11%
Private Equity
1.45%
Research Firm
0.11%
其他
31.58%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
56
23.72M
59.74%
-1.53M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
2023Q2
163
30.56M
83.28%
-10.69M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Bain Capital Life Sciences Investors, LLC
8.43M
21.24%
--
--
Jun 30, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.44%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
8.96%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.68%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.65%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
904.36K
2.28%
+14.09K
+1.58%
Jun 30, 2025
Parkman Healthcare Partners LLC
913.44K
2.3%
+177.82K
+24.17%
Jun 30, 2025
Schonfeld Strategic Advisors LLC
1.04M
2.61%
+8.86K
+0.86%
Jun 30, 2025
Advent International L.P.
577.78K
1.46%
--
--
Jun 30, 2025
Spignesi (Robert G JR)
493.93K
1.24%
-378.44K
-43.38%
Jul 14, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
占比0.02%
Dimensional US Core Equity 1 ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Rapid Micro Biosystems Inc的前五大股东是谁?

Rapid Micro Biosystems Inc 的前五大股东如下:
Bain Capital Life Sciences Investors, LLC持有股份:8.43M,占总股份比例:21.24%。
Kennedy Lewis Investment Management LLC持有股份:4.94M,占总股份比例:12.44%。
Longitude Capital Management Co., LLC持有股份:3.56M,占总股份比例:8.96%。
Endeavour Medtech Growth II LP持有股份:2.26M,占总股份比例:5.68%。
Ally Bridge Group (HK) Limited持有股份:1.85M,占总股份比例:4.65%。

Rapid Micro Biosystems Inc的前三大股东类型是什么?

Rapid Micro Biosystems Inc 的前三大股东类型分别是:
Bain Capital Life Sciences Investors, LLC
Kennedy Lewis Investment Management LLC
Longitude Capital Management Co., LLC

有多少机构持有Rapid Micro Biosystems Inc(RPID)的股份?

截至2025Q3,共有56家机构持有Rapid Micro Biosystems Inc的股份,合计持有的股份价值约为23.72M,占公司总股份的59.74%。与2025Q2相比,机构持股有所增加,增幅为-11.56%。

哪个业务部门对Rapid Micro Biosystems Inc的收入贡献最大?

在FY2025Q2,Product revenue业务部门对Rapid Micro Biosystems Inc的收入贡献最大,创收4.42M,占总收入的60.85%。
KeyAI